Clinical characteristics, molecular epidemiology and mechanisms of colistin heteroresistance in Enterobacter cloacae complex

IntroductionColistin has emerged as the last resort for treating multidrug-resistant Enterobacter cloacae complex (ECC) infections. The primary purposes of this study were to demonstrate the presence of colistin heteroresistance in ECC and to further investigate their clinical characteristics, molec...

Full description

Saved in:
Bibliographic Details
Main Authors: Chunli Wei, Jiming Wu, Jisheng Zhang, Youtao Liang, Kaixin Yu, Mingjing Liao, Xushan Liang, Jianmin Wang, Wenzhang Long, Jin Wang, Shijian Chen, Yang Yang, Xue Gong, Jie Li, Xiaoli Zhang
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-03-01
Series:Frontiers in Cellular and Infection Microbiology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fcimb.2025.1536058/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849706056876294144
author Chunli Wei
Jiming Wu
Jisheng Zhang
Youtao Liang
Kaixin Yu
Kaixin Yu
Mingjing Liao
Xushan Liang
Jianmin Wang
Wenzhang Long
Jin Wang
Shijian Chen
Yang Yang
Xue Gong
Jie Li
Xiaoli Zhang
author_facet Chunli Wei
Jiming Wu
Jisheng Zhang
Youtao Liang
Kaixin Yu
Kaixin Yu
Mingjing Liao
Xushan Liang
Jianmin Wang
Wenzhang Long
Jin Wang
Shijian Chen
Yang Yang
Xue Gong
Jie Li
Xiaoli Zhang
author_sort Chunli Wei
collection DOAJ
description IntroductionColistin has emerged as the last resort for treating multidrug-resistant Enterobacter cloacae complex (ECC) infections. The primary purposes of this study were to demonstrate the presence of colistin heteroresistance in ECC and to further investigate their clinical characteristics, molecular epidemiology and mechanisms.MethodsPopulation analysis profiles (PAP) were performed to confirm the heteroresistance phenotype. Average nucleotide identity (ANI) was determined to classify ECC species. Phylogenetic analysis based on core genome single nucleotide polymorphisms (cg-SNPs), multilocus sequence typing (MLST) and core genome MLST (cg-MLST). Risk factors and clinical outcomes of infections were analyzed through a retrospective case-control study. Potential mechanisms of colistin heteroresistance were evaluated using polymerase chain reaction (PCR), efflux pump inhibition assays and reverse transcription quantitative PCR (RT-qPCR).ResultsA high proportion (24.4%) of the non-resistant strains were colistin-heteroresistant isolates. Among the several ECC species, Enterobacter kobei had the largest percentage (29.4%) of colistin-heteroresistant isolates, followed by Enterobacter hormaechei (20.5%) and Enterobacter bugandensis (20.0%). Notably, only one strain (0.8%; 1/132) of Enterobacter hormaechei was fully resistant to colistin. Different ECC species showed varying heteroresistance levels: Enterobacter roggenkampii, Enterobacter kobei, Enterobacter asburiae and Enterobacter bugandensis displayed high heteroresistance levels  (MIC ≥ 128 mg/L). 75% of all ST116 and ST56 strains were heteroresistant to colistin. The infection of ST116 and ST56 strains as well as exposure to cephalosporin antibiotics were independent risk factors for colistin-heteroresistant ECC infections. Mechanistic analysis revealed that heteroresistance strongly correlated with the overexpression of arnA, regulated by the PhoPQ two-component system (TCS). Notably, mgrB had minimal impact. AcrAB-TolC efflux pump genes showed unsynchronized expression; High acrB expression was strongly associated with colistin heteroresistance, while acrA and tolC were not.DiscussionColistin heteroresistance showed species-dependent variations in levels and prevalence rates. The colistin-heteroresistant mechanisms were complex, involving coordinated regulation of multiple genes. These results highlighted the need for tailored antimicrobial stewardship. In addition, the development of direct, reliable and rapid clinical methods for detecting heteroresistance is essential for improving infection management and prevention.
format Article
id doaj-art-c5e7191eb12c4c43a68caa8fafe1de5c
institution DOAJ
issn 2235-2988
language English
publishDate 2025-03-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Cellular and Infection Microbiology
spelling doaj-art-c5e7191eb12c4c43a68caa8fafe1de5c2025-08-20T03:16:18ZengFrontiers Media S.A.Frontiers in Cellular and Infection Microbiology2235-29882025-03-011510.3389/fcimb.2025.15360581536058Clinical characteristics, molecular epidemiology and mechanisms of colistin heteroresistance in Enterobacter cloacae complexChunli Wei0Jiming Wu1Jisheng Zhang2Youtao Liang3Kaixin Yu4Kaixin Yu5Mingjing Liao6Xushan Liang7Jianmin Wang8Wenzhang Long9Jin Wang10Shijian Chen11Yang Yang12Xue Gong13Jie Li14Xiaoli Zhang15Department of Microbiology, Yongchuan Hospital of Chongqing Medical University, Chongqing, ChinaDepartment of Microbiology, Yongchuan Hospital of Chongqing Medical University, Chongqing, ChinaDepartment of Microbiology, Yongchuan Hospital of Chongqing Medical University, Chongqing, ChinaDepartment of Microbiology, Yongchuan Hospital of Chongqing Medical University, Chongqing, ChinaDepartment of Microbiology, Yongchuan Hospital of Chongqing Medical University, Chongqing, ChinaDepartment of Pathogenic Biology, Basic Medicine of Jiamusi University, Jiamusi, ChinaDepartment of Microbiology, Yongchuan Hospital of Chongqing Medical University, Chongqing, ChinaDepartment of Microbiology, Yongchuan Hospital of Chongqing Medical University, Chongqing, ChinaDepartment of Microbiology, Yongchuan Hospital of Chongqing Medical University, Chongqing, ChinaDepartment of Microbiology, Yongchuan Hospital of Chongqing Medical University, Chongqing, ChinaDepartment of Microbiology, Yongchuan Hospital of Chongqing Medical University, Chongqing, ChinaDepartment of Microbiology, Yongchuan Hospital of Chongqing Medical University, Chongqing, ChinaDepartment of Microbiology, Yongchuan Hospital of Chongqing Medical University, Chongqing, ChinaDepartment of Microbiology, Yongchuan Hospital of Chongqing Medical University, Chongqing, ChinaDepartment of Microbiology, Yongchuan Hospital of Chongqing Medical University, Chongqing, ChinaDepartment of Microbiology, Yongchuan Hospital of Chongqing Medical University, Chongqing, ChinaIntroductionColistin has emerged as the last resort for treating multidrug-resistant Enterobacter cloacae complex (ECC) infections. The primary purposes of this study were to demonstrate the presence of colistin heteroresistance in ECC and to further investigate their clinical characteristics, molecular epidemiology and mechanisms.MethodsPopulation analysis profiles (PAP) were performed to confirm the heteroresistance phenotype. Average nucleotide identity (ANI) was determined to classify ECC species. Phylogenetic analysis based on core genome single nucleotide polymorphisms (cg-SNPs), multilocus sequence typing (MLST) and core genome MLST (cg-MLST). Risk factors and clinical outcomes of infections were analyzed through a retrospective case-control study. Potential mechanisms of colistin heteroresistance were evaluated using polymerase chain reaction (PCR), efflux pump inhibition assays and reverse transcription quantitative PCR (RT-qPCR).ResultsA high proportion (24.4%) of the non-resistant strains were colistin-heteroresistant isolates. Among the several ECC species, Enterobacter kobei had the largest percentage (29.4%) of colistin-heteroresistant isolates, followed by Enterobacter hormaechei (20.5%) and Enterobacter bugandensis (20.0%). Notably, only one strain (0.8%; 1/132) of Enterobacter hormaechei was fully resistant to colistin. Different ECC species showed varying heteroresistance levels: Enterobacter roggenkampii, Enterobacter kobei, Enterobacter asburiae and Enterobacter bugandensis displayed high heteroresistance levels  (MIC ≥ 128 mg/L). 75% of all ST116 and ST56 strains were heteroresistant to colistin. The infection of ST116 and ST56 strains as well as exposure to cephalosporin antibiotics were independent risk factors for colistin-heteroresistant ECC infections. Mechanistic analysis revealed that heteroresistance strongly correlated with the overexpression of arnA, regulated by the PhoPQ two-component system (TCS). Notably, mgrB had minimal impact. AcrAB-TolC efflux pump genes showed unsynchronized expression; High acrB expression was strongly associated with colistin heteroresistance, while acrA and tolC were not.DiscussionColistin heteroresistance showed species-dependent variations in levels and prevalence rates. The colistin-heteroresistant mechanisms were complex, involving coordinated regulation of multiple genes. These results highlighted the need for tailored antimicrobial stewardship. In addition, the development of direct, reliable and rapid clinical methods for detecting heteroresistance is essential for improving infection management and prevention.https://www.frontiersin.org/articles/10.3389/fcimb.2025.1536058/fullEnterobacter cloacae complexcolistin heteroresistanceresistant subpopulationsprevalencerisk factorsmechanisms
spellingShingle Chunli Wei
Jiming Wu
Jisheng Zhang
Youtao Liang
Kaixin Yu
Kaixin Yu
Mingjing Liao
Xushan Liang
Jianmin Wang
Wenzhang Long
Jin Wang
Shijian Chen
Yang Yang
Xue Gong
Jie Li
Xiaoli Zhang
Clinical characteristics, molecular epidemiology and mechanisms of colistin heteroresistance in Enterobacter cloacae complex
Frontiers in Cellular and Infection Microbiology
Enterobacter cloacae complex
colistin heteroresistance
resistant subpopulations
prevalence
risk factors
mechanisms
title Clinical characteristics, molecular epidemiology and mechanisms of colistin heteroresistance in Enterobacter cloacae complex
title_full Clinical characteristics, molecular epidemiology and mechanisms of colistin heteroresistance in Enterobacter cloacae complex
title_fullStr Clinical characteristics, molecular epidemiology and mechanisms of colistin heteroresistance in Enterobacter cloacae complex
title_full_unstemmed Clinical characteristics, molecular epidemiology and mechanisms of colistin heteroresistance in Enterobacter cloacae complex
title_short Clinical characteristics, molecular epidemiology and mechanisms of colistin heteroresistance in Enterobacter cloacae complex
title_sort clinical characteristics molecular epidemiology and mechanisms of colistin heteroresistance in enterobacter cloacae complex
topic Enterobacter cloacae complex
colistin heteroresistance
resistant subpopulations
prevalence
risk factors
mechanisms
url https://www.frontiersin.org/articles/10.3389/fcimb.2025.1536058/full
work_keys_str_mv AT chunliwei clinicalcharacteristicsmolecularepidemiologyandmechanismsofcolistinheteroresistanceinenterobactercloacaecomplex
AT jimingwu clinicalcharacteristicsmolecularepidemiologyandmechanismsofcolistinheteroresistanceinenterobactercloacaecomplex
AT jishengzhang clinicalcharacteristicsmolecularepidemiologyandmechanismsofcolistinheteroresistanceinenterobactercloacaecomplex
AT youtaoliang clinicalcharacteristicsmolecularepidemiologyandmechanismsofcolistinheteroresistanceinenterobactercloacaecomplex
AT kaixinyu clinicalcharacteristicsmolecularepidemiologyandmechanismsofcolistinheteroresistanceinenterobactercloacaecomplex
AT kaixinyu clinicalcharacteristicsmolecularepidemiologyandmechanismsofcolistinheteroresistanceinenterobactercloacaecomplex
AT mingjingliao clinicalcharacteristicsmolecularepidemiologyandmechanismsofcolistinheteroresistanceinenterobactercloacaecomplex
AT xushanliang clinicalcharacteristicsmolecularepidemiologyandmechanismsofcolistinheteroresistanceinenterobactercloacaecomplex
AT jianminwang clinicalcharacteristicsmolecularepidemiologyandmechanismsofcolistinheteroresistanceinenterobactercloacaecomplex
AT wenzhanglong clinicalcharacteristicsmolecularepidemiologyandmechanismsofcolistinheteroresistanceinenterobactercloacaecomplex
AT jinwang clinicalcharacteristicsmolecularepidemiologyandmechanismsofcolistinheteroresistanceinenterobactercloacaecomplex
AT shijianchen clinicalcharacteristicsmolecularepidemiologyandmechanismsofcolistinheteroresistanceinenterobactercloacaecomplex
AT yangyang clinicalcharacteristicsmolecularepidemiologyandmechanismsofcolistinheteroresistanceinenterobactercloacaecomplex
AT xuegong clinicalcharacteristicsmolecularepidemiologyandmechanismsofcolistinheteroresistanceinenterobactercloacaecomplex
AT jieli clinicalcharacteristicsmolecularepidemiologyandmechanismsofcolistinheteroresistanceinenterobactercloacaecomplex
AT xiaolizhang clinicalcharacteristicsmolecularepidemiologyandmechanismsofcolistinheteroresistanceinenterobactercloacaecomplex